MEDFIELD, Mass., June 28, 2010 (GLOBE NEWSWIRE) -- Symbollon Pharmaceuticals, Inc. (OTCBB:SYMBA) (www.symbollon.com) is pleased to announce that it continues to build its retail broker network for Iogen™. Artisan Natural Products Brokerage has agreed to join the Symbollon team to represent Iogen in the Northern California region. Artisan Natural Products Brokerage provides extensive coverage to all Health Food stores and retail chains in the Natural Products industry. Artisan Natural Products Brokerage is led by Andrea Juras Piatt, a veteran of 29 years, specializing in the supplement and cosmetic retail business. Iogen is the first dietary supplement formulated to promote breast health for women. Iogen has been clinically tested in over 2,000 women with fibrocystic breast disease, including breast pain and tenderness and benign breast lumps and cysts.
"We are excited to join forces with Andrea," stated Paul C. Desjourdy, President and Chief Executive Officer of Symbollon. "Her years of experience representing dietary supplements in the Northern California area will be of great help to Iogen as we continue to expand into the retail market. We will continue to pursue additional retail distribution channels for our product. We are committed to making Iogen available in as many outlets as possible so every woman who has interest in improving her breast health has easy access to Iogen."
"I truly believe Iogen is a product that will ease most women's concerns with breast health," noted Andrea Juras Piatt, President of Artisan Natural Products Brokerage. "Iogen is the first of its kind, a proven clinically safe product with impressive efficacy."
Through Artisan's efforts, Iogen is already available in the following Northern California locations:
- Country Sun Natural Foods, Palo Alto, CA
- Down To Earth, San Jose, CA
- Staff of Life, Santa Cruz, CA
- New Leaf Markets, Santa Cruz, CA
- Vitamin Center, Los Gatos, CA
- Way of Life, Capitola, CA
About Symbollon Pharmaceuticals, Inc. (OTCBB:SYMBA)
Symbollon is a specialty life science company focused on the development and commercialization of proprietary products based on its molecular iodine technology for women's healthcare and antimicrobials uses. Iogen is a dietary supplement formulated for women suffering from the symptoms of fibrocystic breast disease, including breast pain and tenderness and benign breast lumps and cysts. For more information about Symbollon, please visit the company's website at http://www.symbollon.com. For more information about Iogen, please visit http://www.buyiogen.com.
The Symbollon Pharmaceuticals, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7640
Forward-Looking Statement This news release contains statements by the Company that involve risks and uncertainties and may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from those currently anticipated as a result of a number of factors, including, but not limited to, the risks and uncertainties associated with whether (i) we will be able to successfully commercialize Iogen, (ii) Symbollon will be able to obtain the resources necessary to continue operations as a going concern, (iii) the Company will be able to enter into new arrangements with corporate partners, (iv) Symbollon will be able to commercialize other products and (vi) such other factors as may be disclosed from time-to-time in the Company's reports as filed with the Securities and Exchange Commission.